Article info

Download PDFPDF

Early ocular surface and tear film status in congenital aniridia indicates a supportive treatment window

Authors

  • Fabian N Fries Department of Ophthalmology, Saarland University Hospital and Saarland University Faculty of Medicine, Homburg, Germany Dr. Rolf M. Schwiete Center for Limbal Stem Cell and Aniridia Research, Saarland University, Homburg, Saar, Germany PubMed articlesGoogle scholar articles
  • Kayed Moslemani Department of Ophthalmology, Saarland University Hospital and Saarland University Faculty of Medicine, Homburg, Germany PubMed articlesGoogle scholar articles
  • Tor Paaske Utheim Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway Department of Ophthalmology, Sørlandet Hospital Arendal, Arendal, Norway PubMed articlesGoogle scholar articles
  • Berthold Seitz Department of Ophthalmology, Saarland University Hospital and Saarland University Faculty of Medicine, Homburg, Germany PubMed articlesGoogle scholar articles
  • Barbara Käsmann-Kellner Department of Ophthalmology, Saarland University Hospital and Saarland University Faculty of Medicine, Homburg, Germany PubMed articlesGoogle scholar articles
  • Neil S Lagali Department of Ophthalmology, Sørlandet Hospital Arendal, Arendal, Norway Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Neil S Lagali, Department of Biomedical and Clinical Sciences, Linköping University, Linköping 581 83, Sweden; neil.lagali{at}liu.se
View Full Text

Citation

Fries FN, Moslemani K, Utheim TP, et al
Early ocular surface and tear film status in congenital aniridia indicates a supportive treatment window

Publication history

  • Received January 24, 2022
  • Accepted November 29, 2022
  • First published December 14, 2022.
Online issue publication 
December 18, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.